Zebra Capital Management LLC lowered its position in shares of HCA Healthcare Inc (NYSE:HCA) by 14.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,815 shares of the company’s stock after selling 1,756 shares during the quarter. HCA Healthcare accounts for approximately 0.5% of Zebra Capital Management LLC’s investment portfolio, making the stock its 25th largest position. Zebra Capital Management LLC’s holdings in HCA Healthcare were worth $1,110,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in HCA. FMR LLC boosted its stake in HCA Healthcare by 54.9% during the second quarter. FMR LLC now owns 5,488,273 shares of the company’s stock valued at $563,097,000 after buying an additional 1,944,961 shares in the last quarter. Renaissance Technologies LLC boosted its stake in HCA Healthcare by 187.9% during the second quarter. Renaissance Technologies LLC now owns 1,094,431 shares of the company’s stock valued at $112,289,000 after buying an additional 714,331 shares in the last quarter. LSV Asset Management boosted its stake in HCA Healthcare by 9.2% during the second quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock valued at $560,133,000 after buying an additional 457,752 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in HCA Healthcare by 62.6% during the second quarter. Massachusetts Financial Services Co. MA now owns 891,489 shares of the company’s stock valued at $91,466,000 after buying an additional 343,121 shares in the last quarter. Finally, Canada Pension Plan Investment Board boosted its stake in HCA Healthcare by 65.3% during the second quarter. Canada Pension Plan Investment Board now owns 800,500 shares of the company’s stock valued at $82,131,000 after buying an additional 316,250 shares in the last quarter. 70.40% of the stock is owned by institutional investors and hedge funds.

HCA has been the subject of several research reports. Morgan Stanley raised their target price on HCA Healthcare from $105.00 to $115.00 and gave the company an “underweight” rating in a research note on Thursday, August 16th. SunTrust Banks reaffirmed a “buy” rating and set a $125.00 target price on shares of HCA Healthcare in a research note on Friday, July 20th. Credit Suisse Group raised their target price on HCA Healthcare from $122.00 to $143.00 and gave the company an “outperform” rating in a research note on Friday, July 27th. Leerink Swann raised their target price on HCA Healthcare from $140.00 to $150.00 and gave the company an “outperform” rating in a research note on Tuesday, September 4th. Finally, Piper Jaffray Companies reaffirmed a “hold” rating and set a $124.00 target price on shares of HCA Healthcare in a report on Thursday, July 26th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $126.33.

Shares of NYSE HCA opened at $131.50 on Thursday. HCA Healthcare Inc has a 12 month low of $71.18 and a 12 month high of $138.18. The firm has a market cap of $45.60 billion, a PE ratio of 19.95, a P/E/G ratio of 1.19 and a beta of 0.54. The company has a debt-to-equity ratio of -7.64, a current ratio of 1.36 and a quick ratio of 1.15.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Wednesday, July 25th. The company reported $2.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.16 by $0.13. The firm had revenue of $11.53 billion during the quarter, compared to the consensus estimate of $11.32 billion. HCA Healthcare had a negative return on equity of 61.68% and a net margin of 6.21%. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.73 EPS. research analysts anticipate that HCA Healthcare Inc will post 9.23 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 28th. Investors of record on Tuesday, September 4th will be paid a $0.35 dividend. This represents a $1.40 annualized dividend and a yield of 1.06%. The ex-dividend date of this dividend is Friday, August 31st. HCA Healthcare’s dividend payout ratio is currently 21.24%.

In related news, insider Jonathan B. Perlin sold 12,500 shares of the stock in a transaction dated Thursday, June 21st. The stock was sold at an average price of $108.00, for a total value of $1,350,000.00. Following the completion of the sale, the insider now directly owns 107,894 shares of the company’s stock, valued at approximately $11,652,552. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Kathryn A. Torres sold 1,530 shares of the stock in a transaction dated Friday, July 27th. The stock was sold at an average price of $124.47, for a total value of $190,439.10. Following the completion of the sale, the senior vice president now directly owns 9,307 shares of the company’s stock, valued at $1,158,442.29. The disclosure for this sale can be found here. Over the last three months, insiders sold 182,757 shares of company stock valued at $22,468,053. Company insiders own 2.80% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: Investing in Dividend Stocks

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.